642 related articles for article (PubMed ID: 16965416)
21. Effects of narrowband UV-B on pharmacodynamic markers of response to therapy: an immunohistochemical study over sequential samples.
Carrascosa JM; Tapia G; Bielsa I; Fuente MJ; Ferrandiz C
J Cutan Pathol; 2007 Oct; 34(10):769-76. PubMed ID: 17880582
[TBL] [Abstract][Full Text] [Related]
22. Expression of antiapoptotic protein c-FLIP is upregulated in psoriasis epidermis.
Yang J; Li Y; Liu YQ; Long JW; Tian F; Dong J; Shen GX; Tu YT; Tao J
Eur J Dermatol; 2009; 19(1):29-33. PubMed ID: 19059832
[TBL] [Abstract][Full Text] [Related]
23. Balance of Treg vs. T-helper cells in the transition from symptomless to lesional psoriatic skin.
Keijsers RR; van der Velden HM; van Erp PE; de Boer-van Huizen RT; Joosten I; Koenen HJ; van de Kerkhof PC
Br J Dermatol; 2013 Jun; 168(6):1294-302. PubMed ID: 23330679
[TBL] [Abstract][Full Text] [Related]
24. Antigen-independent expansion of T cells from psoriatic skin lesions: phenotypic characterization and antigen reactivity.
Horrocks C; Holder JE; Berth-Jones J; Camp RD
Br J Dermatol; 1997 Sep; 137(3):331-8. PubMed ID: 9349325
[TBL] [Abstract][Full Text] [Related]
25. Tight junction components occludin, ZO-1, and claudin-1, -4 and -5 in active and healing psoriasis.
Peltonen S; Riehokainen J; Pummi K; Peltonen J
Br J Dermatol; 2007 Mar; 156(3):466-72. PubMed ID: 17300235
[TBL] [Abstract][Full Text] [Related]
26. Photoaging-associated changes in epidermal proliferative cell fractions in vivo.
Kwon OS; Yoo HG; Han JH; Lee SR; Chung JH; Eun HC
Arch Dermatol Res; 2008 Jan; 300(1):47-52. PubMed ID: 17968567
[TBL] [Abstract][Full Text] [Related]
27. Suprabasal expression of human amphiregulin in the epidermis of transgenic mice induces a severe, early-onset, psoriasis-like skin pathology: expression of amphiregulin in the basal epidermis is also associated with synovitis.
Cook PW; Brown JR; Cornell KA; Pittelkow MR
Exp Dermatol; 2004 Jun; 13(6):347-56. PubMed ID: 15186320
[TBL] [Abstract][Full Text] [Related]
28. Comparative analysis of normal and psoriatic skin both in vivo and in vitro.
Mils V; Basset-Séguin N; Molès JP; Tesnière A; Leigh I; Guilhou JJ
Differentiation; 1994 Nov; 58(1):77-86. PubMed ID: 7532603
[TBL] [Abstract][Full Text] [Related]
29. The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis.
Debets R; Hegmans JP; Croughs P; Troost RJ; Prins JB; Benner R; Prens EP
J Immunol; 1997 Mar; 158(6):2955-63. PubMed ID: 9058835
[TBL] [Abstract][Full Text] [Related]
30. Flexural versus plaque lesions in psoriasis: an immunohistochemical differentiation.
Vissers WH; Roelofzen J; De Jong EM; Van Erp PE; Van de Kerkhof PC
Eur J Dermatol; 2005; 15(1):13-7. PubMed ID: 15701587
[TBL] [Abstract][Full Text] [Related]
31. Assessment of epidermal dendritic cell markers and T-lymphocytes in psoriasis.
Jones JL; Berth-Jones J; Fletcher A; Hutchinson PE
J Pathol; 1994 Oct; 174(2):77-82. PubMed ID: 7525911
[TBL] [Abstract][Full Text] [Related]
32. Aberrant integrin expression during epidermal wound healing and in psoriatic epidermis.
Hertle MD; Kubler MD; Leigh IM; Watt FM
J Clin Invest; 1992 Jun; 89(6):1892-901. PubMed ID: 1601996
[TBL] [Abstract][Full Text] [Related]
33. Localization of endothelial proliferation and microvascular expansion in active plaque psoriasis.
Creamer D; Allen MH; Sousa A; Poston R; Barker JN
Br J Dermatol; 1997 Jun; 136(6):859-65. PubMed ID: 9217817
[TBL] [Abstract][Full Text] [Related]
34. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
[TBL] [Abstract][Full Text] [Related]
35. Increased expression of interleukin-4 receptors on psoriatic epidermal cells.
Prens E; Hegmans J; Lien RC; Debets R; Troost R; van Joost T; Benner R
Am J Pathol; 1996 May; 148(5):1493-502. PubMed ID: 8623919
[TBL] [Abstract][Full Text] [Related]
36. Flow cytometric identification of proliferative subpopulations within normal human epidermis and the localization of the primary hyperproliferative population in psoriasis.
Bata-Csorgo Z; Hammerberg C; Voorhees JJ; Cooper KD
J Exp Med; 1993 Oct; 178(4):1271-81. PubMed ID: 7690831
[TBL] [Abstract][Full Text] [Related]
37. The changes in expression of ICAM-3, Ki-67, PCNA, and CD31 in psoriatic lesions before and after methotrexate treatment.
Yazici AC; Tursen U; Apa DD; Ikizoglu G; Api H; Baz K; Tasdelen B
Arch Dermatol Res; 2005 Dec; 297(6):249-55. PubMed ID: 16215763
[TBL] [Abstract][Full Text] [Related]
38. Early epidermal response after a single dose of gamma-rays in organotypic culture of human breast skin.
Donetti E; Bedoni M; Boschini E; Bertelli AA; Sforza C; Gagliano N
Br J Dermatol; 2005 Nov; 153(5):881-6. PubMed ID: 16225595
[TBL] [Abstract][Full Text] [Related]
39. Simulating psoriasis by altering transit amplifying cells.
Grabe N; Neuber K
Bioinformatics; 2007 Jun; 23(11):1309-12. PubMed ID: 17308343
[TBL] [Abstract][Full Text] [Related]
40. Epidermal hyperproliferation assessed by the monoclonal antibody Ks8.12 on frozen sections.
de Mare S; Van Erp PE; van de Kerkhof PC
J Invest Dermatol; 1989 Jan; 92(1):130-1. PubMed ID: 2462594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
